These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

203 related articles for article (PubMed ID: 27699546)

  • 21. Cancer Immunology and HPV.
    Wollenberg B
    Recent Results Cancer Res; 2017; 206():243-248. PubMed ID: 27699544
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immune response during therapy with cisplatin or radiation for human papillomavirus-related head and neck cancer.
    Spanos WC; Nowicki P; Lee DW; Hoover A; Hostager B; Gupta A; Anderson ME; Lee JH
    Arch Otolaryngol Head Neck Surg; 2009 Nov; 135(11):1137-46. PubMed ID: 19917928
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Human Papillomavirus Associated Cancers of the Head and Neck: An Australian Perspective.
    Aldalwg MAH; Brestovac B
    Head Neck Pathol; 2017 Sep; 11(3):377-384. PubMed ID: 28176136
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The pathology of HPV-related head and neck cancer: implications for the diagnostic pathologist.
    Westra WH
    Semin Diagn Pathol; 2015 Jan; 32(1):42-53. PubMed ID: 25804343
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Epidemiology of human papillomavirus-related head and neck cancer.
    Joseph AW; D'Souza G
    Otolaryngol Clin North Am; 2012 Aug; 45(4):739-64. PubMed ID: 22793850
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Detection of Human Papilloma Virus and Risk Factors among Patients with Head and Neck Squamous Cell Carcinoma Attending a Tertiary Referral Centre in South India.
    Bandhary SK; Shetty V; Saldanha M; Gatti P; Devegowda D; R PS; Shetty AK
    Asian Pac J Cancer Prev; 2018 May; 19(5):1325-1330. PubMed ID: 29802694
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Incidence trends in head and neck squamous cell carcinoma in Slovenia, 1983-2009: role of human papillomavirus infection.
    Strojan P; Zadnik V; Šifrer R; Lanišnik B; Didanović V; Jereb S; Poljak M; Kocjan BJ; Gale N
    Eur Arch Otorhinolaryngol; 2015 Dec; 272(12):3805-14. PubMed ID: 25542247
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antitumor activity of human papillomavirus type 16 E7-specific T cells against virally infected squamous cell carcinoma of the head and neck.
    Albers A; Abe K; Hunt J; Wang J; Lopez-Albaitero A; Schaefer C; Gooding W; Whiteside TL; Ferrone S; DeLeo A; Ferris RL
    Cancer Res; 2005 Dec; 65(23):11146-55. PubMed ID: 16322265
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HPV-positive status associated with inflamed immune microenvironment and improved response to anti-PD-1 therapy in head and neck squamous cell carcinoma.
    Wang J; Sun H; Zeng Q; Guo XJ; Wang H; Liu HH; Dong ZY
    Sci Rep; 2019 Sep; 9(1):13404. PubMed ID: 31527697
    [TBL] [Abstract][Full Text] [Related]  

  • 30. HPV-associated head and neck cancers in the Asia Pacific: A critical literature review & meta-analysis.
    Shaikh MH; McMillan NA; Johnson NW
    Cancer Epidemiol; 2015 Dec; 39(6):923-38. PubMed ID: 26523982
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Enhanced Radiation Sensitivity of Human Papillomavirus-Driven Head and Neck Cancer: Focus on Immunological Aspects.
    Özcan-Wahlbrink M; Schifflers C; Riemer AB
    Front Immunol; 2019; 10():2831. PubMed ID: 31849993
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPV Integration in HNSCC Correlates with Survival Outcomes, Immune Response Signatures, and Candidate Drivers.
    Koneva LA; Zhang Y; Virani S; Hall PB; McHugh JB; Chepeha DB; Wolf GT; Carey TE; Rozek LS; Sartor MA
    Mol Cancer Res; 2018 Jan; 16(1):90-102. PubMed ID: 28928286
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HPV genotypes and their prognostic significance in head and neck squamous cell carcinomas.
    Rautava J; Kuuskoski J; Syrjänen K; Grenman R; Syrjänen S
    J Clin Virol; 2012 Feb; 53(2):116-20. PubMed ID: 22177275
    [TBL] [Abstract][Full Text] [Related]  

  • 34. An Update on Cellular MicroRNA Expression in Human Papillomavirus-Associated Head and Neck Squamous Cell Carcinoma.
    Emmett S; Whiteman DC; Panizza BJ; Antonsson A
    Oncology; 2018; 95(4):193-201. PubMed ID: 29920485
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Human papillomavirus (HPV) and oropharyngeal squamous cell carcinoma.
    Dalianis T
    Presse Med; 2014 Dec; 43(12 Pt 2):e429-34. PubMed ID: 25455638
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The role of human papillomavirus in head and neck cancer.
    Lajer CB; von Buchwald C
    APMIS; 2010 Jun; 118(6-7):510-9. PubMed ID: 20553531
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Immunological network analysis in HPV associated head and neck squamous cancer and implications for disease prognosis.
    Chen X; Yan B; Lou H; Shen Z; Tong F; Zhai A; Wei L; Zhang F
    Mol Immunol; 2018 Apr; 96():28-36. PubMed ID: 29477933
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Molecular Patterns and Biology of HPV-Associated HNSCC.
    Brakenhoff RH; Wagner S; Klussmann JP
    Recent Results Cancer Res; 2017; 206():37-56. PubMed ID: 27699528
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Population-based evidence of increased survival in human papillomavirus-related head and neck cancer.
    Nygård M; Aagnes B; Bray F; Møller B; Mork J
    Eur J Cancer; 2012 Jun; 48(9):1341-6. PubMed ID: 22516210
    [TBL] [Abstract][Full Text] [Related]  

  • 40. HPV in Head and Neck Cancer-30 Years of History.
    Syrjänen S; Rautava J; Syrjänen K
    Recent Results Cancer Res; 2017; 206():3-25. PubMed ID: 27699526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.